DE60117858D1 - Zusammensetzung zur behandlung von entzündlichen erkrankungen - Google Patents
Zusammensetzung zur behandlung von entzündlichen erkrankungenInfo
- Publication number
- DE60117858D1 DE60117858D1 DE60117858T DE60117858T DE60117858D1 DE 60117858 D1 DE60117858 D1 DE 60117858D1 DE 60117858 T DE60117858 T DE 60117858T DE 60117858 T DE60117858 T DE 60117858T DE 60117858 D1 DE60117858 D1 DE 60117858D1
- Authority
- DE
- Germany
- Prior art keywords
- vesicle
- treatment
- composition
- inflammatory diseases
- mole percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/797—Lipid particle
- Y10S977/798—Lipid particle having internalized material
- Y10S977/799—Containing biological material
- Y10S977/801—Drug
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00204372 | 2000-12-07 | ||
EP00204372 | 2000-12-07 | ||
PCT/EP2001/014633 WO2002045688A2 (en) | 2000-12-07 | 2001-12-07 | Composition for treatment of inflammatory disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60117858D1 true DE60117858D1 (de) | 2006-05-04 |
DE60117858T2 DE60117858T2 (de) | 2006-11-30 |
Family
ID=8172392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60117858T Expired - Lifetime DE60117858T2 (de) | 2000-12-07 | 2001-12-07 | Zusammensetzung zur behandlung von entzündlichen erkrankungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US7955618B2 (de) |
EP (1) | EP1347743B1 (de) |
JP (1) | JP4623931B2 (de) |
AT (1) | ATE319428T1 (de) |
AU (2) | AU3169702A (de) |
CA (1) | CA2430897C (de) |
DE (1) | DE60117858T2 (de) |
DK (1) | DK1347743T3 (de) |
ES (1) | ES2260321T3 (de) |
PT (1) | PT1347743E (de) |
WO (1) | WO2002045688A2 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1347743T3 (da) | 2000-12-07 | 2006-07-03 | Univ Utrecht Holding Bv | Præparat til behandling af inflammatoriske lidelser |
US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
EP1371362A1 (de) * | 2002-06-12 | 2003-12-17 | Universiteit Utrecht Holding B.V. | Zusammensetzung zur Behandlung entzündlicher Erkrankungen |
EP1393720A1 (de) * | 2002-08-27 | 2004-03-03 | Universiteit Utrecht | Vesikel enthaltend Corticosteroide zur Behandlung von Krebs |
WO2005011633A1 (ja) * | 2003-08-01 | 2005-02-10 | National Institute Of Advanced Industrial Science And Technology | 標的指向性リポソームを含む炎症性疾患治療薬または診断薬 |
US20050255154A1 (en) | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
JP2008512445A (ja) | 2004-09-09 | 2008-04-24 | イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム | 炎症状態の治療のためのリポソーム性グルココルチコイドの使用 |
ES2384641T3 (es) | 2005-07-14 | 2012-07-10 | Lithera, Inc. | Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo |
JP2010506941A (ja) * | 2006-10-17 | 2010-03-04 | リセラ,インク. | 甲状腺眼症の治療のための方法、組成物及び製剤 |
US20090155207A1 (en) * | 2007-11-29 | 2009-06-18 | Hariri Robert J | Use of Immunomodulatory Compounds for the Treatment of Transverse Myelitis, Multiple Sclerosis, and Other Disorders |
EP2127639A1 (de) * | 2008-05-26 | 2009-12-02 | Universiteit Utrecht Holding B.V. | Corticosteroid enthaltende Liposomen zur Behandlung von kardiovaskulären Erkrankungen |
US20100016265A1 (en) * | 2008-07-16 | 2010-01-21 | Qaiser Yusuf | Anti-inflammatory composition and method for preparation |
US9132084B2 (en) * | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
KR20120113267A (ko) * | 2010-01-15 | 2012-10-12 | 리쎄라 인코오포레이티드 | 동결건조 케이크 제제 |
EA201270784A1 (ru) | 2010-11-24 | 2013-04-30 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" | Монотерапевтические композиции селективного липофильного и бета-агониста длительного действия и способы косметического лечения ожирения и контурного выпячивания |
TR201818978T4 (tr) | 2011-11-04 | 2019-01-21 | Enceladus Pharmaceuticals B V | İnsanlardaki İnflamatuvar Rahatsızlıkların Tedavisine Yönelik Lipozomal Kortikosteroidler |
US9186326B2 (en) * | 2014-07-21 | 2015-11-17 | Kimia Zist Parsian (Kzp) | Method and system for synthesizing nanocarrier based long acting drug delivery system for dexamethasone |
CA2997286A1 (en) * | 2015-09-14 | 2017-03-23 | Vgsk Technologies, Inc. | A sterically stabilized carrier for subcutaneous, sublingual and oral therapeutics, compositions and methods for treating a mammal |
WO2017188818A1 (en) | 2016-04-29 | 2017-11-02 | Enceladus Pharmaceuticals B.V. | Liposomal corticosteroids for topical injection in inflamed lesions or areas |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2002185A (en) * | 1930-06-26 | 1935-05-21 | Prosperity Co Inc | Garment or ironing press |
GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
US4522803A (en) * | 1983-02-04 | 1985-06-11 | The Liposome Company, Inc. | Stable plurilamellar vesicles, their preparation and use |
US4994443A (en) * | 1982-12-20 | 1991-02-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
IL79114A (en) | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
DE3542773A1 (de) * | 1985-12-04 | 1987-06-11 | Roehm Pharma Gmbh | Hautwirksame pharmaka mit liposomen als wirkstofftraeger |
US4818537A (en) * | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
IL91664A (en) * | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
US5139803A (en) * | 1989-02-09 | 1992-08-18 | Nabisco, Inc. | Method and liposome composition for the stabilization of oxidizable substances |
FR2648462B1 (fr) * | 1989-06-15 | 1994-01-28 | Oreal | Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede |
US5356633A (en) * | 1989-10-20 | 1994-10-18 | Liposome Technology, Inc. | Method of treatment of inflamed tissues |
US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US5474765A (en) * | 1992-03-23 | 1995-12-12 | Ut Sw Medical Ctr At Dallas | Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells |
US5989586A (en) | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
CA2120197A1 (en) | 1993-04-02 | 1994-10-03 | Kenji Endo | Stable aqueous dispersions containing liposomes |
JPH07316040A (ja) * | 1994-03-29 | 1995-12-05 | Res Dev Corp Of Japan | 再構成リポソームと物質導入方法 |
US5786344A (en) * | 1994-07-05 | 1998-07-28 | Arch Development Corporation | Camptothecin drug combinations and methods with reduced side effects |
JPH08198777A (ja) * | 1995-01-25 | 1996-08-06 | Taisho Pharmaceut Co Ltd | 注射用脂肪乳剤 |
KR100506958B1 (ko) * | 1995-12-15 | 2005-10-27 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | 액정디스플레이 장치 |
JPH09278672A (ja) * | 1996-04-12 | 1997-10-28 | Green Cross Corp:The | 薬物含有脂肪乳剤 |
DK0850646T3 (da) * | 1996-06-18 | 2008-05-13 | Kyowa Hakko Kogyo Kk | Liposompræparater af indolocarbazol-derivater |
DK0929293T3 (da) * | 1996-08-23 | 2004-02-02 | Sequus Pharm Inc | Liposomer indeholdende en cisplatinforbindelse |
US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US5758659A (en) | 1997-03-26 | 1998-06-02 | Thompson; Robert B. | Wound tab condom and method of application |
US20020159951A1 (en) | 1997-05-06 | 2002-10-31 | Unger Evan C. | Novel targeted compositions for diagnostic and therapeutic use |
WO1998050041A1 (en) | 1997-05-06 | 1998-11-12 | Imarx Pharmaceutical Corp. | Novel prodrugs comprising fluorinated amphiphiles |
US6506783B1 (en) * | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
US6316260B1 (en) * | 1997-08-22 | 2001-11-13 | Bernina Biosystems Gmbh | Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof |
WO2000025748A1 (fr) * | 1998-11-02 | 2000-05-11 | Terumo Kabushiki Kaisha | Liposomes |
CZ20012038A3 (cs) | 1998-12-23 | 2001-09-12 | Idea Ag | Zdokonalený přípravek pro topické, neinvazivní použití in vivo |
US6270806B1 (en) * | 1999-03-03 | 2001-08-07 | Elan Pharma International Limited | Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
WO2001000174A1 (fr) | 1999-06-25 | 2001-01-04 | Terumo Kabushiki Kaisha | Liposomes |
ATE317869T1 (de) * | 1999-07-14 | 2006-03-15 | Alza Corp | Neutrales lipopolymer und liposomale zusammensetzungen daraus |
EP1072617A1 (de) | 1999-07-30 | 2001-01-31 | Universiteit van Utrecht | Temperaturempfindliche Polymere |
US6511676B1 (en) * | 1999-11-05 | 2003-01-28 | Teni Boulikas | Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
US20030050236A1 (en) * | 2000-08-15 | 2003-03-13 | The University Of Chicago | Compounds that enhance tumor death |
TWI230616B (en) * | 2000-09-25 | 2005-04-11 | Ind Tech Res Inst | Liposome for incorporating large amounts of hydrophobic substances |
DK1347743T3 (da) | 2000-12-07 | 2006-07-03 | Univ Utrecht Holding Bv | Præparat til behandling af inflammatoriske lidelser |
EP1371362A1 (de) | 2002-06-12 | 2003-12-17 | Universiteit Utrecht Holding B.V. | Zusammensetzung zur Behandlung entzündlicher Erkrankungen |
US20050152962A1 (en) * | 2002-06-12 | 2005-07-14 | Metselaar Josbert M. | Composition for treatment of inflammatory disorders |
EP1393720A1 (de) | 2002-08-27 | 2004-03-03 | Universiteit Utrecht | Vesikel enthaltend Corticosteroide zur Behandlung von Krebs |
-
2001
- 2001-12-07 DK DK01991836T patent/DK1347743T3/da active
- 2001-12-07 PT PT01991836T patent/PT1347743E/pt unknown
- 2001-12-07 JP JP2002547474A patent/JP4623931B2/ja not_active Expired - Fee Related
- 2001-12-07 AT AT01991836T patent/ATE319428T1/de active
- 2001-12-07 AU AU3169702A patent/AU3169702A/xx active Pending
- 2001-12-07 CA CA2430897A patent/CA2430897C/en not_active Expired - Lifetime
- 2001-12-07 AU AU2002231697A patent/AU2002231697B2/en not_active Ceased
- 2001-12-07 WO PCT/EP2001/014633 patent/WO2002045688A2/en active IP Right Grant
- 2001-12-07 DE DE60117858T patent/DE60117858T2/de not_active Expired - Lifetime
- 2001-12-07 ES ES01991836T patent/ES2260321T3/es not_active Expired - Lifetime
- 2001-12-07 EP EP01991836A patent/EP1347743B1/de not_active Expired - Lifetime
-
2003
- 2003-06-05 US US10/455,257 patent/US7955618B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1347743A2 (de) | 2003-10-01 |
WO2002045688A3 (en) | 2002-11-14 |
CA2430897A1 (en) | 2002-06-13 |
DK1347743T3 (da) | 2006-07-03 |
PT1347743E (pt) | 2006-06-30 |
ES2260321T3 (es) | 2006-11-01 |
JP4623931B2 (ja) | 2011-02-02 |
WO2002045688A2 (en) | 2002-06-13 |
US20040037875A1 (en) | 2004-02-26 |
ATE319428T1 (de) | 2006-03-15 |
JP2004517835A (ja) | 2004-06-17 |
CA2430897C (en) | 2010-11-16 |
AU2002231697B2 (en) | 2006-09-07 |
EP1347743B1 (de) | 2006-03-08 |
US7955618B2 (en) | 2011-06-07 |
AU3169702A (en) | 2002-06-18 |
DE60117858T2 (de) | 2006-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE319428T1 (de) | Zusammensetzung zur behandlung von entzündlichen erkrankungen | |
ATE406873T1 (de) | Zusammensetzung zur behandlung entzündlicher erkrankungen | |
Dokka et al. | Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes | |
FI971494A (fi) | Eetterilipidiloposomit sekä niiden terapeuttinen käyttö | |
DE69033856D1 (de) | Verabreichungssystem für phospholipide | |
AU2003258686A1 (en) | Vesicle-encapsulated corticosteroids for the treatment of cancer | |
ATE337019T1 (de) | Geladene lipide und deren verwendung | |
ES2173420T3 (es) | Comprimidos que contienen un antibiotico de beta-lactamico y procedimiento para su produccion. | |
AU2003304237A1 (en) | Gel-stabilized nanoparticulate active agent compositions | |
AR015919A1 (es) | Formas de dosificacion de liberacion sostenida de sertralina, sales de sertralina ,composicion farmaceutica, procedimiento depreparacion y su uso en terapias. | |
TR200101307T2 (tr) | Antranilik asit amidler ve ilaç olarak kullanılmaları. | |
PT850046E (pt) | Microemulsoes para utilizacao como veiculos para administracao de compostos activos | |
ATE152614T1 (de) | Mittel zur behandlung entzündeter gewebe | |
NO980047D0 (no) | Blanding for tildeling av et polart medikament i kolon | |
CR7936A (es) | Formulaciones parenterales de un peptido para el tratamiento de lupus sitemico eritematoso | |
FI956014A (fi) | Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon | |
DK0873351T3 (da) | Steroidnitrit/nitratesterderivater anvendelige som antiinflammatoriske lægemidler | |
SE9704833D0 (sv) | New formulation | |
ATE310512T1 (de) | Verwendung von lipoxinen zur inhibierung von tnf- alpha initiierter gegenreaktion | |
EA200300110A1 (ru) | Композиция элетриптана в виде частиц | |
BR9712329A (pt) | Veículos contendo um éter lipídio/combinação de lipídio formado complementarmente e os usos terapêuticos dos mesmos | |
ES8707111A1 (es) | Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas. | |
ES2084348T3 (es) | N-((4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il)carbonil)aminoacidos utiles en la terapia de afecciones osteoarticulares. | |
GEP20053512B (en) | S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders. | |
YU24603A (sh) | Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: ENCELADUS PHARMACEUTICALS B.V., AMSTERDAM, NL |